OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Changing perspectives in atopic dermatitis
E. Serra‐Baldrich, F.J. Ortiz de Frutos, I Jáuregui, et al.
Allergologia et Immunopathologia (2017) Vol. 46, Iss. 4, pp. 397-412
Closed Access | Times Cited: 24
E. Serra‐Baldrich, F.J. Ortiz de Frutos, I Jáuregui, et al.
Allergologia et Immunopathologia (2017) Vol. 46, Iss. 4, pp. 397-412
Closed Access | Times Cited: 24
Showing 24 citing articles:
Inflammatory Skin Diseases: Focus on the Role of Suppressors of Cytokine Signaling (SOCS) Proteins
Antonia Cianciulli, Rosa Calvello, Chiara Porro, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 505-505
Open Access | Times Cited: 9
Antonia Cianciulli, Rosa Calvello, Chiara Porro, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 505-505
Open Access | Times Cited: 9
Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis
Lotte S. Spekhorst, Marlies de Graaf, Nicolaas P. A. Zuithoff, et al.
JAMA Dermatology (2022) Vol. 158, Iss. 9, pp. 1048-1048
Open Access | Times Cited: 29
Lotte S. Spekhorst, Marlies de Graaf, Nicolaas P. A. Zuithoff, et al.
JAMA Dermatology (2022) Vol. 158, Iss. 9, pp. 1048-1048
Open Access | Times Cited: 29
Treatment of moderate‐to‐severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series
José Carlos Armario Hita, J Rodríguez, J.F. Silvestre, et al.
British Journal of Dermatology (2019) Vol. 181, Iss. 5, pp. 1072-1074
Closed Access | Times Cited: 46
José Carlos Armario Hita, J Rodríguez, J.F. Silvestre, et al.
British Journal of Dermatology (2019) Vol. 181, Iss. 5, pp. 1072-1074
Closed Access | Times Cited: 46
Artesunate attenuates 2, 4-dinitrochlorobenzene-induced atopic dermatitis by down-regulating Th17 cell responses in BALB/c mice
Xinyu Bai, Ping Liu, Yee-Wen Chai, et al.
European Journal of Pharmacology (2020) Vol. 874, pp. 173020-173020
Closed Access | Times Cited: 43
Xinyu Bai, Ping Liu, Yee-Wen Chai, et al.
European Journal of Pharmacology (2020) Vol. 874, pp. 173020-173020
Closed Access | Times Cited: 43
Long-term efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a prospective real-world cohort study in China
Yuyi Wang, Ruiling Jia, Hu Qin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Yuyi Wang, Ruiling Jia, Hu Qin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Topical Pioglitazone Nanoformulation for the Treatment of Atopic Dermatitis: Design, Characterization and Efficacy in Hairless Mouse Model
Lupe Carolina Espinoza, Rodrigo Vera, Marcelle Silva-Abreu, et al.
Pharmaceutics (2020) Vol. 12, Iss. 3, pp. 255-255
Open Access | Times Cited: 32
Lupe Carolina Espinoza, Rodrigo Vera, Marcelle Silva-Abreu, et al.
Pharmaceutics (2020) Vol. 12, Iss. 3, pp. 255-255
Open Access | Times Cited: 32
Fifty‐two week follow‐up safety and effectiveness results of dupilumab treatment of moderate‐to‐severe atopic dermatitis from a retrospective, multicentric series
Ricardo Ruíz‐Villaverde, J.J. Domínguez-Cruz, José Carlos Armario Hita, et al.
Dermatologic Therapy (2019), pp. e12931-e12931
Open Access | Times Cited: 29
Ricardo Ruíz‐Villaverde, J.J. Domínguez-Cruz, José Carlos Armario Hita, et al.
Dermatologic Therapy (2019), pp. e12931-e12931
Open Access | Times Cited: 29
Consensus on the Clinical Approach to Moderate-to-Severe Atopic Dermatitis in Spain: A Delphi Survey
J. Sastre, E. Serra‐Baldrich, José Carlos Armario Hita, et al.
Dermatology Research and Practice (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 17
J. Sastre, E. Serra‐Baldrich, José Carlos Armario Hita, et al.
Dermatology Research and Practice (2020) Vol. 2020, pp. 1-10
Open Access | Times Cited: 17
Glycerol 85% efficacy on atopic skin and its microbiome: a randomized controlled trial with clinical and bacteriological evaluation
Randa Youssef, Vanessa Hafez, Yasmine Samy Elkholy, et al.
Journal of Dermatological Treatment (2019) Vol. 32, Iss. 7, pp. 730-736
Closed Access | Times Cited: 15
Randa Youssef, Vanessa Hafez, Yasmine Samy Elkholy, et al.
Journal of Dermatological Treatment (2019) Vol. 32, Iss. 7, pp. 730-736
Closed Access | Times Cited: 15
Factors Associated with Atopic Dermatitis among Children Aged 6 to 14 Years in Alimosho Local Government, Lagos, Nigeria
Olubunmi Kayode, Charlotte Mokoatle, Phoka C. Rathebe, et al.
Children (2023) Vol. 10, Iss. 5, pp. 893-893
Open Access | Times Cited: 3
Olubunmi Kayode, Charlotte Mokoatle, Phoka C. Rathebe, et al.
Children (2023) Vol. 10, Iss. 5, pp. 893-893
Open Access | Times Cited: 3
Atopic dermatitis incidence and risk factors in young adults in Castellon (Spain): A prospective cohort study
Alberto Arnedo-Pena, Joan Puig‐Barberà, Adrián Artero-Civera, et al.
Allergologia et Immunopathologia (2020) Vol. 48, Iss. 6, pp. 694-700
Open Access | Times Cited: 8
Alberto Arnedo-Pena, Joan Puig‐Barberà, Adrián Artero-Civera, et al.
Allergologia et Immunopathologia (2020) Vol. 48, Iss. 6, pp. 694-700
Open Access | Times Cited: 8
Prevalence of atopic dermatitis in the adolescent population of Catalonia (Spain)
Toni Mora, Irene Sánchez‐Collado, Joaquim Mullol, et al.
Allergologia et Immunopathologia (2023) Vol. 51, Iss. 4, pp. 101-109
Open Access | Times Cited: 2
Toni Mora, Irene Sánchez‐Collado, Joaquim Mullol, et al.
Allergologia et Immunopathologia (2023) Vol. 51, Iss. 4, pp. 101-109
Open Access | Times Cited: 2
Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus
J Rodríguez, E. Serra‐Baldrich, Ricardo Ruíz‐Villaverde, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv12314-adv12314
Open Access | Times Cited: 2
J Rodríguez, E. Serra‐Baldrich, Ricardo Ruíz‐Villaverde, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv12314-adv12314
Open Access | Times Cited: 2
104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain
J Rodríguez, J.J. Domínguez-Cruz, José Carlos Armario Hita, et al.
Anais Brasileiros de Dermatologia (2021) Vol. 96, Iss. 6, pp. 787-790
Open Access | Times Cited: 5
J Rodríguez, J.J. Domínguez-Cruz, José Carlos Armario Hita, et al.
Anais Brasileiros de Dermatologia (2021) Vol. 96, Iss. 6, pp. 787-790
Open Access | Times Cited: 5
Atopic dermatitis in pediatric population from Catalonia: A retrospective, large‐scale population‐based study
Toni Mora, Irene Sánchez‐Collado, Joaquim Mullol, et al.
Pediatric Allergy and Immunology (2024) Vol. 35, Iss. 5
Open Access
Toni Mora, Irene Sánchez‐Collado, Joaquim Mullol, et al.
Pediatric Allergy and Immunology (2024) Vol. 35, Iss. 5
Open Access
Role of regulatory T cells in pathogenesis and therapeutics of atopic dermatitis
Shagufta Rather, Ananya Sharma, Kaushal K. Verma
Elsevier eBooks (2024), pp. 573-595
Closed Access
Shagufta Rather, Ananya Sharma, Kaushal K. Verma
Elsevier eBooks (2024), pp. 573-595
Closed Access
Microbial Dynamics: Assessing Skincare Regimens’ Impact on the Facial Skin Microbiome and Skin Health Parameters
Nicole Wagner, Valerie Diane Valeriano, Samuel Diou-Hirtz, et al.
Microorganisms (2024) Vol. 12, Iss. 12, pp. 2655-2655
Open Access
Nicole Wagner, Valerie Diane Valeriano, Samuel Diou-Hirtz, et al.
Microorganisms (2024) Vol. 12, Iss. 12, pp. 2655-2655
Open Access
Factors Associated with Atopic Dermatitis among Children Aged 6 To 14 Years in Alimosho Local Government, Lagos, Nigeria
Olubunmi Kayode, Charlotte Mokoatle, Phoka C. Rathebe, et al.
(2023)
Open Access | Times Cited: 1
Olubunmi Kayode, Charlotte Mokoatle, Phoka C. Rathebe, et al.
(2023)
Open Access | Times Cited: 1
Prevalence and Predictors of Anxiety and Depressive Symptoms among Adult Patients with Atopic Dermatitis in Malaysia Tertiary Referral Hospital
Nur Hafidah Ishak, Seng Choi Chong, Normala Ibrahim, et al.
Malaysian Journal of Medicine and Health Sciences (2023) Vol. 19, Iss. 4, pp. 193-200
Open Access
Nur Hafidah Ishak, Seng Choi Chong, Normala Ibrahim, et al.
Malaysian Journal of Medicine and Health Sciences (2023) Vol. 19, Iss. 4, pp. 193-200
Open Access
Exploring daily practice performance of dupilumab in atopic dermatitis
Lotte S. Spekhorst
(2023)
Open Access
Lotte S. Spekhorst
(2023)
Open Access
Actualización en la patogenia y tratamiento de la dermatitis atópica
Ignasi Figueras‐Nart, M. Bonfill Ortí
Piel (2018) Vol. 33, Iss. 7, pp. 457-471
Closed Access
Ignasi Figueras‐Nart, M. Bonfill Ortí
Piel (2018) Vol. 33, Iss. 7, pp. 457-471
Closed Access
Actualización en el tratamiento de la dermatitis atópica
Fernando Valenzuela, Jacob Yumha Laiz
Piel (2018) Vol. 34, Iss. 3, pp. 180-185
Closed Access
Fernando Valenzuela, Jacob Yumha Laiz
Piel (2018) Vol. 34, Iss. 3, pp. 180-185
Closed Access
Atopic Dermatitis: From Physiopathology to the Clinics
Ignasi Figueras‐Nart, Oscar Palomares-Gracia
IntechOpen eBooks (2019)
Open Access
Ignasi Figueras‐Nart, Oscar Palomares-Gracia
IntechOpen eBooks (2019)
Open Access
Segurança e eficácia de 104 semanas de dupilumabe no tratamento de dermatite atópica grave. A experiência de cinco unidades dermatológicas de referência na Espanha
J Rodríguez, J.J. Domínguez-Cruz, José Carlos Armario Hita, et al.
(2021) Vol. 96, Iss. 6, pp. 787-790
Open Access
J Rodríguez, J.J. Domínguez-Cruz, José Carlos Armario Hita, et al.
(2021) Vol. 96, Iss. 6, pp. 787-790
Open Access
